ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a phenotype demonstrating a lack of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2).